Company
News
Investors
Contacts
Careers
Services
GMP Compliance
Pre-GMP development
Production
Quality Assurance
Quality control
Regulatory Support
Commercial Manufacturing
Commercial products at PolyPeptide
Late stage development
Process development and optimization
Capacity and Capabilities
Custom R&D
Custom Research Grade Peptides
Radiolabeled peptide
Generic peptides
Services
GMP Compliance
Pre-GMP development
Production
Quality Assurance
Quality control
Regulatory Support
Commercial Manufacturing
Commercial products at PolyPeptide
Late stage development
Process development and optimization
Capacity and Capabilities
Custom R&D
Custom Research Grade Peptides
Radiolabeled peptide
Generic peptides
✕
2026
Home
Investors
Results and presentations
2026
Results and presentations
2026
2025
2024
2023
2022
2021
2020
2019
2026
Presentations and webcasts
Healthcare Investor Meeting, Genolier (CH), CEO presentation, March 2026
Company
News
Investors
Contacts
Careers
